Literature DB >> 3168693

Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

C Sacchetti1, M Capello, P Rebecchi, L Roncucci, G Zanghieri, A Tripodi, M Ponz de Leon.   

Abstract

The frequency of gastroduodenal lesions has been investigated in 142 patients with liver cirrhosis of various degrees of severity and in 63 patients with mild liver disease (controls) in whom liver biopsy excluded nodular regeneration. Cirrhotic patients were subdivided in three groups according to the Pugh modification of the Child-Turcotte criteria. Although the frequency of peptic ulcer was not different, gastroduodenal erosions were observed more frequently in cirrhotics than in controls (29.6% vs 11.1%, P less than 0.01). The occurrence of erosions was related to the severity of the disease: in Child A and B patients their frequency was 21 and 26% respectively, but rose to 48.4 (15 of 31 vs 7 of 63 in controls, P less than 0.001) in the Child C group. Both mild and severe gastroduodenitis occurred more frequently, although not significantly, in patients with liver cirrhosis. All together one or more endoscopic lesions were observed in almost 60% of cirrhotics but only in 25.4% of controls (P less than 0.001). In conclusion, our data do not show an increased prevalence of peptic ulcer in cirrhotic patients; in contrast, liver cirrhosis is significantly associated with the endoscopic finding of gastroduodenal erosions, especially in the more advanced stages of the disease. These findings would suggest a cautious use, in cirrhotic patients, of drugs which may damage the gastroduodenal mucosa; moreover, long-term administration of antacids or of other drugs with a protective effect on gastroduodenal mucosa might be taken into consideration for Child C patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168693     DOI: 10.1007/bf01536669

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  The source of bleeding in portal hypertension.

Authors:  P Sandblom
Journal:  Bull Soc Int Chir       Date:  1975

2.  Erosive gastritis in cirrhosis; influence of portal hypertension on the gastric mucosa.

Authors:  E D PALMER
Journal:  Am J Dig Dis       Date:  1957-01

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

Review 4.  Benefit of endoscopy in upper gastrointestinal bleeding in patients with liver disease.

Authors:  R S Koff
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

5.  To scope or not to scope.

Authors:  H O Conn
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

6.  Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.

Authors:  H Orrego; H Kalant; Y Israel; J Blake; A Medline; J G Rankin; A Armstrong; B Kapur
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

7.  Morphology of gastric microcirculation in cirrhosis.

Authors:  M Hashizume; K Tanaka; K Inokuchi
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

8.  Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

Authors:  T T McCormack; J Sims; I Eyre-Brook; H Kennedy; J Goepel; A G Johnson; D R Triger
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

9.  Prognostic value of the aminopyrine breath test in cirrhotic patients.

Authors:  J P Villeneuve; C Infante-Rivard; M Ampelas; G Pomier-Layrargues; P M Huet; D Marleau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

10.  Emergency endoscopy after gastrointestinal haemorrhage in 50 patients with portal hypertension.

Authors:  R Waldram; M Davis; H Nunnerley; R Williams
Journal:  Br Med J       Date:  1974-10-12
View more
  10 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

3.  Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis.

Authors:  Tomotaka Akatsu; Masashi Yoshida; Shigeyuki Kawachi; Minoru Tanabe; Motohide Shimazu; Koichiro Kumai; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2006-10-06       Impact factor: 3.199

4.  Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus.

Authors:  Dulciene Maria Magalhães Queiroz; Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Sarah Maria Singulano Cinque; Adriana Gonçalves Oliveira; Alicia Godoy; Hugo Tanno
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

5.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

6.  Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

Authors:  J J Chen; C S Changchien; D I Tai; S S Chiou; C M Lee; C H Kuo
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

7.  Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.

Authors:  J C Delchier; F Roudot-Thoraval; L Stanescu; M C Deharvengt; L Elouaer Blanc
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 8.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

9.  Helicobacter pylori infection and peptic ulcer disease in cirrhosis.

Authors:  C J Tsai
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

10.  Upper and lower gastrointestinal diseases in liver transplant candidates.

Authors:  G Gravante; D Delogu; D Venditti
Journal:  Int J Colorectal Dis       Date:  2007-10-12       Impact factor: 2.571

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.